Klingman & Associates, LLC Boston Scientific Corp Transaction History
Klingman & Associates, LLC
- $1.8 Billion
- Q2 2025
A detailed history of Klingman & Associates, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Klingman & Associates, LLC holds 1,914 shares of BSX stock, worth $182,614. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,914Holding current value
$182,614% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BSX
# of Institutions
1,913Shares Held
1.26BCall Options Held
9.71MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$13.1 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.22 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.31 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.23 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $137B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...